SCHEDULE 13G

Statement of Beneficial Ownership

ArriVent BioPharma, Inc. Filed 2026-01-21 Acc 0002012383-26-000643

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-10-13 SCHEDULE 13G Statement of Beneficial Ownership
2026-01-21 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-30 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)